Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solvay SA M&A Activity 2014

May 8, 2014

4005_iss_2014-05-08_726c3d5e-258b-4ced-9a28-2fba73ed01a2.pdf

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

European Commission clears proposed Solvay/INEOS joint venture

Brussels, May 8th, 2014 --- Solvay and INEOS have today obtained European Commission clearance for their proposed 50/50 chlorvinyls Joint Venture.

Commission clearance is subject to implementation of an agreed remedy package comprising divestment of the following INEOS owned assets:

  • · the membrane chlorine plant and EDC/ VCM plants at Tessenderlo, Belgium
  • · the PVC plant at Mazingarbe, France
  • · the PVC plant at Beek, the Netherlands
  • · the PVC and VCM plants at Wilhelmshaven, Germany
  • · the EDC plants at Runcorn, UK.

In addition, the Commission requires the membrane chlorine plant at Runcorn to be placed in a Joint Venture between the INEOS/ Solvay Joint Venture and the new owner of the aforementioned plants.

The required remedy package must be implemented before the Joint Venture can be formed.

INEOS and Solvay will continue to run their businesses separately until completion of the transaction, which is expected in Q4 2014.

FOLLOW US ON TWITTER @SOLVAYGROUP

As an international chemical group, SOLVAY assists industries in finding and implementing ever more responsible and valuecreating solutions. Solvay generates 90% of its net sales in activities where it is among the world's top three players. It serves many markets, varying from energy and the environment to automotive and aeronautics or electricity and electronics, with one goal: to raise the performance of its clients and improve society's quality of life. The group is headquartered in Brussels, employs about 29,400 people in 56 countries and generated 9.9 billion euros in net sales in 2013. Solvay SA (SOLB.BE) is listed on NYSE EURONEXT in Brussels and Paris (Bloomberg: SOLB:BB - Reuters: SOLB.BR).

INEOS is a global manufacturer of petrochemicals, speciality chemicals and oil products. It comprises 15 businesses each with a major chemical company heritage. Its production network spans 51 manufacturing facilities in 11 countries throughout the world. INEOS products make a significant contribution to saving life, improving health and enhancing standards of living for people around the world. Its businesses produce the raw materials that are essential in the manufacture of a wide variety of goods: from paints to plastics, textiles to technology, medicines to mobile phones - chemicals manufactured by INEOS enhance almost every aspect of modern life.

CONTACTS AT SOLVAY

Lamia Narcisse
Media Relations
+33 1 53 56 59 62
Caroline Jacobs
Media Relations
+32 2 264 1530
Maria Alcon
Investor Relations
+32 2 264 1984
Geoffroy Raskin
Investor Relations
+32 2 264 1540
Edward Mackay
Investor Relations
+32 2 264 3687
CONTACTS AT INEOS
Richard Longden Craig Welsh Louise Calviou
Media Relations Media Relations Investor Relations
+ 41 216 277 063 + 44 19 28 511 528 + 44 1928 516 644

Ce communiqué de presse est également disponible en français. - Dit persbericht is ook in het Nederlands beschikbaar.